Business · 08/05/2003Updated: 10/17/2026 · 1 min read
US Patent Office Extends Patent for Fel-O-Vax FIV Vaccine
Summary
The US Patent and Trademark Office has determined the regulatory review period for the Fel-O-Vax FIV Vaccine, allowing the patent to be extended for a veterinary biologic.
Original source language: Federal Register — Agriculture DepartmentOpen original release →